How to Wean Off Wegovy: What the Evidence Actually Tells Us

What STEP 4 revealed about stopping semaglutide mid-treatment

The clearest picture of what happens when you wean off Wegovy comes from the STEP 4 randomised controlled trial, published in the New England Journal of Medicine. Participants who had already lost weight on 2.4 mg semaglutide were then assigned either to continue or to switch to placebo. Those who stopped regained, on average, around two-thirds of the weight they had lost, within 52 weeks. Cardiometabolic markers that had improved (blood pressure, waist circumference, blood sugar) largely drifted back too.

That finding is not a reason to feel disheartened. It tells us something clinically important: for many people, obesity behaves like a chronic condition that requires ongoing management, not a problem fixed by a finite course of treatment. The body's appetite-signalling hormones, suppressed while on semaglutide, tend to return to their previous levels once the medicine is stopped. Hunger comes back. Gastric emptying accelerates again. The physiological environment that made weight loss difficult in the first place reasserts itself. Understanding this helps explain why clinicians prefer a planned, supported stopping process over simply running out of pens.

If you want to understand more about how semaglutide produces these effects in the first place, the page on how Wegovy works covers the mechanism in detail. For a broader overview of the medicine itself, our Wegovy page is a practical starting point.

Does weaning off Wegovy gradually make a difference?

The honest answer is: probably not in terms of safety, but possibly in terms of comfort and weight stability. There is no pharmacological evidence that a step-down schedule (for instance, dropping from 2.4 mg to 1.7 mg to 1.0 mg over several months) prevents the weight regain seen in STEP 4. The semaglutide is clearing your system regardless of the pace, and the hormonal rebound follows.

Where a gradual reduction can help some people is psychologically and behaviourally. A slower pace gives more time to embed the dietary habits and activity patterns built during treatment. It may soften the transition rather than remove the medicine abruptly. Some prescribers favour this approach for patients who feel anxious about stopping, not because the evidence demands it, but because the patient experience warrants it. This is one reason the question of whether you should wean off Wegovy does not have a single correct answer; it depends on your clinical situation, your weight trajectory and what support is in place. The should you wean off Wegovy page explores the decision framework in more detail.

What is clear from NHS guidance on weight-management medicines is that stopping treatment requires a plan. The NHS England guidance on weight-management injections is explicit that lifestyle support needs to be embedded alongside (and ideally beyond) any course of treatment.

Practical considerations when reducing or stopping Wegovy

If you and your prescriber decide that stopping or stepping down is the right move, a few practical points are worth knowing before the conversation.

Appetite tends to return within a few weeks of stopping. Many people find the first month the most challenging, the sense of fullness that Wegovy provided fades, and hunger returns with more urgency than they remember. Keeping protein intake high and maintaining regular meals can help manage this transition. Our page on how to wean off Wegovy without gaining weight goes into the lifestyle side of this in practical terms.

On the cost side, some patients stopping treatment are, in part, responding to the monthly outlay. It is worth knowing what you are getting for that price before making the decision, the Wegovy cost page sets out what private treatment typically includes and what to compare. A pause, rather than a permanent stop, is sometimes the right choice.

Missed doses during a taper are a slightly different situation. If you are deliberately spacing doses further apart as part of a reducing plan, your prescriber needs to know, the dosing schedule should be adjusted formally, not improvised. For anyone on a higher maintenance dose considering the best approach to stepping down, the best way to wean off Wegovy page discusses the options.

If you are thinking about stopping because of a side effect rather than a planned decision, that is a separate conversation. Side effects often ease after the first few weeks on each dose level, and a pause or dose reduction may be preferable to stopping entirely. A prescriber can advise. We also know from the NHS semaglutide medicines page that most gastrointestinal effects are transient and manageable, stopping abruptly is rarely the only option.

If any of this is prompting questions you would rather talk through than read around, our clinical team is available seven days a week. You can find out more about the prescribers behind the service on the clinical team page.